3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Burkitt Lymphoma
21
Lymphoma, Large B-Cell, Diffuse
18
Multiple Myeloma
16
Lymphoma, Non-Hodgkin
14
Leukemia, Myeloid, Acute
14
Lymphoma
12
Myelodysplastic Syndromes
11
Lymphoma, Follicular
11
Lymphoma, B-Cell
11
Recurrence
10
Ovarian Neoplasms
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Lymphoma, Mantle-Cell
8
Leukemia
8
Hodgkin Disease
8
Pancreatic Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Hematologic Neoplasms
6
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Biphenotypic, Acute
5
Anemia, Refractory, with Excess of Blasts
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Sarcoma, Ewing
4
Sarcoma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Interventions
atezolizumab
2
cabozantinib
1
Specimen Handling
1
Immunoglobulin G
1
Disulfides
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Alveolar Soft Part
×
Cyclophosphamide
×
30 days
×
Clear all
No trials found.